UnitedHealth Group (UNH) Price Target Increased to $308.00 by Analysts at Royal Bank of Canada

UnitedHealth Group (NYSE:UNH) had its target price boosted by Royal Bank of Canada to $308.00 in a research report released on Wednesday morning, The Fly reports. Royal Bank of Canada currently has an outperform rating on the healthcare conglomerate’s stock.

A number of other research firms have also recently weighed in on UNH. Bank of America raised their price objective on UnitedHealth Group from $315.00 to $320.00 and gave the stock a buy rating in a research report on Wednesday. Jefferies Financial Group raised their price objective on UnitedHealth Group from $270.00 to $311.00 and gave the stock a buy rating in a research report on Wednesday, October 3rd. ValuEngine raised UnitedHealth Group from a hold rating to a buy rating in a research report on Tuesday, October 2nd. Morgan Stanley raised their price objective on UnitedHealth Group from $278.00 to $305.00 and gave the stock an overweight rating in a research report on Wednesday, September 5th. Finally, Citigroup cut UnitedHealth Group from a buy rating to a neutral rating and set a $288.00 price objective for the company. in a research report on Monday, September 10th. One investment analyst has rated the stock with a hold rating, twenty-three have assigned a buy rating and one has given a strong buy rating to the company. UnitedHealth Group currently has an average rating of Buy and a consensus target price of $286.83.

UnitedHealth Group stock opened at $267.10 on Wednesday. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 0.63. The firm has a market capitalization of $256.06 billion, a PE ratio of 26.52, a price-to-earnings-growth ratio of 1.58 and a beta of 0.73. UnitedHealth Group has a 1-year low of $202.70 and a 1-year high of $272.81.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. The firm had revenue of $56.56 billion during the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The business’s quarterly revenue was up 12.4% on a year-over-year basis. During the same quarter last year, the firm earned $2.66 EPS. As a group, equities research analysts expect that UnitedHealth Group will post 12.72 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 18th. Shareholders of record on Friday, September 7th were given a dividend of $0.90 per share. The ex-dividend date of this dividend was Thursday, September 6th. This represents a $3.60 dividend on an annualized basis and a yield of 1.35%. UnitedHealth Group’s dividend payout ratio is currently 35.75%.

In other UnitedHealth Group news, CEO Steven H. Nelson sold 26,033 shares of UnitedHealth Group stock in a transaction dated Friday, September 7th. The stock was sold at an average price of $270.65, for a total transaction of $7,045,831.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP D Ellen Wilson sold 15,393 shares of UnitedHealth Group stock in a transaction dated Friday, August 24th. The stock was sold at an average price of $264.29, for a total value of $4,068,215.97. Following the sale, the executive vice president now directly owns 66,402 shares of the company’s stock, valued at approximately $17,549,384.58. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 94,568 shares of company stock valued at $24,950,027. 0.87% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Welch Group LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $106,000. Blue Chip Partners Inc. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $107,000. Northwest Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $117,000. Fort L.P. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $119,000. Finally, Kiley Juergens Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $178,000. 85.35% of the stock is owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: How analysts view the yield curve

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply